Category

Drugs and Devices

The FDA and Regulation – Neurosurgery Partners with FDA for Patient Safety, Innovation and Regulatory Reform

By Access to Care, Drugs and Devices, Guest Post, Health, Medical Innovation, Patient Safety, Regulatory ReliefNo Comments
Clemens M. Schirmer, MD, PhD, FAANS, FAHA (left) Vice-Chair, AANS/CNS Communications and Public Relations Committee Geisinger Wilkes Barre, PA Catherine Jeakle Hill (right) Senior Manager for Regulatory Affairs, Washington Office...
Read More

AANS and CNS Release 2017 Legislative and Regulatory Agenda

By Access to Care, Antitrust, Coding and Reimbursement, Congress, Drugs and Devices, Emergency Care, GME, Health, Health Reform, Healthcare Costs, HIT, IPAB, MACRA, MedEd, Medical Innovation, Medical Liability, Medicare, Quality ImprovementNo Comments
On February 14, 2017 the AANS and CNS released their 2017 legislative and regulatory agenda, which includes action items such as improving the health care delivery system, abolishing the Independent...
Read More